[Experimental study on human bone marrow mesenchymal stem cells transfected by SDF-1 cDNA]

Area of Science:

• Biotechnology
• Stem Cell Biology
• Molecular Biology

Background:

• Human bone marrow mesenchymal stem cells (hBMSCs) are crucial for regenerative medicine.
• Stromal cell-derived factor-1 (SDF-1) plays a vital role in stem cell homing and function.
• Modifying hBMSCs to overexpress SDF-1 could enhance their therapeutic potential.

Purpose of the Study:

• To investigate the expression of SDF-1 mRNA in hBMSCs following transfection with an SDF-1 cDNA expression vector.
• To assess the efficiency of lipofectamine 2000-mediated transfection for delivering the SDF-1 vector into hBMSCs.

Main Methods:

• Isolation, culture, and identification of hBMSCs.
• Construction of the SDF-1-pIRES2-EGFP eukaryotic expression vector.
• Transfection of hBMSCs using lipofectamine 2000 and the SDF-1 vector.
• Measurement of transfection efficiency via green fluorescence protein expression and RT-PCR analysis of SDF-1 mRNA levels.

Main Results:

• Successful construction of the SDF-1-pIRES2-EGFP expression vector.
• A significant increase of approximately 20% in SDF-1 mRNA expression was observed in transfected hBMSCs.
• Lipofectamine 2000 enabled instantaneous transfection of the SDF-1 cDNA vector into hBMSCs.

Conclusions:

• SDF-1 cDNA can be transfected into hBMSCs using lipofectamine 2000.
• The current transfection efficiency is insufficient for generating a stable population of modified hBMSCs.
• Further optimization of transfection protocols is necessary to improve efficiency and achieve steady gene transfer.